Clinical Trial Detail

NCT ID NCT01499121
Title Study of Efficacy and Safety of Sunitinib Given on an Individualized Schedule
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Sunnybrook Health Sciences Centre
Indications

clear cell renal cell carcinoma

Therapies

Sunitinib

Age Groups: adult

No variant requirements are available.